Gutfreund John Peter 4
4 · Oncocyte Corp · Filed Aug 17, 2022
Insider Transaction Report
Form 4
Gutfreund John Peter
Director
Transactions
- Award
Option to Purchase Common Stock
2022-08-15+45,000→ 45,000 totalExercise: $0.97Exp: 2032-08-15→ Common Stock (45,000 underlying) - Award
Common Stock, no par value
2022-08-15+10,000→ 10,000 total - Purchase
Common Stock, no par value
2022-08-15$0.93/sh+25,000$23,250→ 25,000 total(indirect: See footnote)
Footnotes (4)
- [F1]The Restricted Stock Units shall vest one year from the date of grant, subject to the Reporting Person's continued service as a director of the Issuer from the date of grant until the vesting date or, if earlier, until the next annual meeting of shareholders.
- [F2]The price of $0.93 per share represents a weighted average of prices ranging from $0.91 to $0.97 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F3]These securities are held by the minor children of the Reporting Person, and the Reporting Person has voting and dispositive control over such securities.
- [F4]Options shall vest one year from the date of grant, subject to the Reporting Person's continued service as a director of the Issuer from the date of grant until the vesting date or, if earlier, until the next annual meeting of shareholders.